Old Web
English
Sign In
Acemap
>
authorDetail
>
Nitzan Sternheim
Nitzan Sternheim
Genentech
Atezolizumab
Oncology
Internal medicine
Medicine
Dosing
5
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Evaluation of atezolizumab immunogenicity: Efficacy and safety (Part 2).
2021
Clinical and Translational Science
Solange Peters
Peter R. Galle
Coen Bernaards
Marcus Ballinger
Rene Bruno
Valerie Quarmby
Jane Ruppel
Alexandr Vilimovskij
Benjamin Wu
Nitzan Sternheim
Martin Reck
Show All
Source
Cite
Save
Citations (0)
Prediction of overall survival in patients across solid tumors following atezolizumab treatments: A tumor growth inhibition–overall survival modeling framework
2021
Phyllis Chan
Mathilde Marchand
Kenta Yoshida
Shweta Vadhavkar
Nina Wang
Alyse Lin
Benjamin Wu
Marcus Ballinger
Nitzan Sternheim
Jin Y. Jin
Rene Bruno
Show All
Source
Cite
Save
Citations (0)
Time-dependent population PK models of single-agent atezolizumab in patients with cancer.
2021
Cancer Chemotherapy and Pharmacology
Mathilde Marchand
Rong Zhang
Phyllis Chan
Valerie Quarmby
Marcus Ballinger
Nitzan Sternheim
Benjamin Wu
Jin Y. Jin
Rene Bruno
Show All
Source
Cite
Save
Citations (2)
Letter to the editor: Model-based simulation to support the extended dosing regimens of atezolizumab.
2021
European Journal of Clinical Pharmacology
Benjamin Wu
Stephanie N. Liu
Marcus Ballinger
Nitzan Sternheim
Hina Patel
Julien Mazières
Rene Bruno
Show All
Source
Cite
Save
Citations (0)
Evaluation of atezolizumab immunogenicity: Clinical pharmacology (part 1)
2021
Clinical and Translational Science
Benjamin Wu
Nitzan Sternheim
Priya Agarwal
Julia Suchomel
Shweta Vadhavkar
Rene Bruno
Marcus Ballinger
Coen Bernaards
Phyllis Chan
Jane Ruppel
Jin Jin
Sandhya Girish
Amita Joshi
Valerie Quarmby
Show All
Source
Cite
Save
Citations (1)
1